Chris Nutting
Overview
Explore the profile of Chris Nutting including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, McQuaid D, Dunlop A, Barnes H, Mohajer J, Smith G, et al.
Adv Radiat Oncol
. 2024 Apr;
9(6):101490.
PMID: 38681895
Purpose: Swallow-related motion of the larynx is most significant in the cranio-caudal directions and of` short duration. Conventional target definition for radical radiation therapy includes coverage of the whole larynx....
2.
Naderi E, Aguado-Barrera M, Schack L, Dorling L, Rattay T, Fachal L, et al.
JNCI Cancer Spectr
. 2023 Oct;
7(6).
PMID: 37862240
Background: This study was designed to identify common genetic susceptibility and shared genetic variants associated with acute radiation-induced toxicity across 4 cancer types (prostate, head and neck, breast, and lung)....
3.
Li M, Nutting C, Zhang T, Gou Q, Liu T
Acta Otolaryngol
. 2023 Jun;
143(6):499-506.
PMID: 37335205
Background: Patients with head and neck cancer (HNC) receiving radiotherapy (RT) are at a high risk of weight loss (WL) due to a variety of nutrition impact symptoms (NISs). Objective:...
4.
Samant P, De Ruysscher D, Hoebers F, Canters R, Hall E, Nutting C, et al.
Clin Transl Radiat Oncol
. 2023 Mar;
39:100595.
PMID: 36880063
Background And Purpose: A popular Normal tissue Complication (NTCP) model deployed to predict radiotherapy (RT) toxicity is the Lyman-Burman Kutcher (LKB) model of tissue complication. Despite the LKB model's popularity,...
5.
Biau J, Nutting C, Langendijk J, Frederic-Moreau T, Thariat J, Piram L, et al.
Radiother Oncol
. 2022 Mar;
170:48-54.
PMID: 35288225
Intensity-modulated radiotherapy has been widely used routinely in recent past years for post-operative radiotherapy of salivary gland cancers Because of the sharp dose fall off outside of target volumes with...
6.
Gupta A, Dunlop A, Mitchell A, McQuaid D, Nill S, Barnes H, et al.
Clin Transl Radiat Oncol
. 2021 Dec;
32:48-51.
PMID: 34849412
Introduction: The Elekta Unity MR-Linac (MRL) has enabled adaptive radiotherapy (ART) for patients with head and neck cancers (HNC). Adapt-To-Shape-Lite (ATS-Lite) is a novel Adapt-to-Shape strategy that provides ART without...
7.
Tyler J, Bernstein D, Seithel M, Rooney K, Petkar I, Miles E, et al.
Phys Imaging Radiat Oncol
. 2021 Nov;
20:46-50.
PMID: 34754954
This study aimed to assess the impact of the margin applied to the clinical target volume, to create the planning target volume, on plan quality of a novel dysphagia-optimised intensity...
8.
Gupta A, Wong K, Newbold K, Bhide S, Nutting C, Harrington K
Front Oncol
. 2021 Oct;
11:753908.
PMID: 34616688
Early-stage squamous cell cancer (SCC) of the glottis has a good prognosis. Therefore, patients have long survival outcomes and may potentially suffer from late toxicities of radiotherapy. Radiotherapy with a...
9.
Vasiliadou I, Breik O, Baker H, Leslie I, Sim V, Hegarty G, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33808781
Nivolumab is an anti-PD-1 monoclonal antibody currently used as immunotherapy for patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) with evidence of disease progression after platinum-based chemotherapy. This...
10.
Petkar I, McQuaid D, Dunlop A, Tyler J, Hall E, Nutting C
Front Oncol
. 2021 Mar;
11:644767.
PMID: 33768005
Background And Purpose: To evaluate the inter-observer variation (IOV) in pharyngeal constrictor muscle (PCM) contouring, and resultant impact on dosimetry and estimated toxicity, as part of the pre-trial radiotherapy trial...